Nucleic Acid Labeling Market Size Worth $3.22 Billion By 2027 | Grand View Research, Inc.

November 02 08:12 2021
Nucleic Acid Labeling Market Size Worth $3.22 Billion By 2027 | Grand View Research, Inc.
“Grand View Research, Inc. – Market Research And Consulting.”
According to a new report published by Grand View Research, The COVID-19 pandemic has also led to an increase in demand for nucleic acid-based research efforts aimed at developing breakthrough treatment solutions, further expected to accelerate market expansion.

The global nucleic acid labeling market size is expected to reach USD 3.22 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.81% from 2020 to 2027. Technological advancements with respect to PCR, DNA sequencing, nanotechnology, and microfluidics are expected to help enhance the market potential in the near future. Additionally, nucleic acid labeling products are gaining significant momentum across diagnostic as well as therapeutic interventions associated with cancer disorders and genetic deformities, thereby elevating the market growth.

Technologies that enable direct detection of specific sequences of RNA or DNA serve as occasional potent alternatives to amplification protocols employed in gene expression studies. Research activities performed on these lines have also led to the development of novel label protocols such as that of incorporating probes that are specifically labeled with anti-label antibodies conjugated via alkaline phosphatase. This direct detection technique employing the use of specific labeled probes has emerged as a reliable and flexible approach for gene expression analysis, well-suited for high-throughput screening.

The continuing quest for designing labels with enhanced functional properties suitable for hybridization assays has led to the introduction of an array of potential approaches to label nucleic acids that are inclusive of genes encoding enzymes, microparticles, and a novel class of fluorophores.

With the emergence of novel viral infections, such as the coronavirus (COVID 19), followed by the MERS outbreak in 2015 and the SARS outbreak in 2003, healthcare professionals are experiencing a significant urge for the development of rapid detection approaches that can assist in the identification of target viruses at scale. The COVID-19 pandemic has also led to an increase in demand for nucleic acid-based research efforts aimed at developing breakthrough treatment solutions, further expected to accelerate market expansion. 

 

Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/nucleic-acid-labeling-market

 

Nucleic Acid Labeling Market Report Highlights

 By product, the reagents segment dominated the market in 2019 and is set to maintain its lead throughout the forecast period. This is attributed to the fact that reagents are essential components across both enzymatic and chemical labeling, resulting in an expanding vendor base aimed at introducing novel and effective reagents to label DNA/RNA

By labeling type, the radioactive or radioisotope labels dominated the market in 2019 and are anticipated to maintain their lead throughout the forecast period. Radioactive labeling is gaining increased traction among the professionals, which is further supplemented by the ease of incorporation of radioactively labeled nucleic acid sequences

The oligonucleotide application segment is expected to grow at the fastest pace from 2020 to 2027. The end labeling of oligonucleotides with radioisotopes has gained immense traction over the years. This is attributed to the fact that such oligonucleotides are set to drive the nucleic acid probe technology, which can be custom made via the information on target RNA and DNAs

North America captured the largest share of 39.47% in 2019, which is primarily attributed to the expanding portfolios of emerging manufacturers, along with robust support from research organizations, collectively contributing to the regional revenue.

Companies are engaged in acquisitions and collaborations to maintain a competitive edge in the market.

 

For Requesting a Sample Copy Please Visit @ https://www.grandviewresearch.com/industry-analysis/nucleic-acid-labeling-market/request/rs5

 

Nucleic Acid Labeling Market Segmentation

Grand View Research has segmented the global nucleic acid labeling market on the basis of product, labeling type, method, application, sector, and region:

Nucleic Acid Labeling Product Outlook (Revenue, USD Million, 2016 – 2027)    

• Kits     

• Reagents     

• Instruments

Nucleic Acid Labeling Type Outlook (Revenue, USD Million, 2016 – 2027)    

• Radioisotope/Radioactive Labels     

• Non-radioactive Labels

Nucleic Acid Labeling Method Outlook (Revenue, USD Million, 2016 – 2027)    

• Enzyme-based             

• PCR             

• 5′ end labeling             

• 3′ end labeling             

• Others     

• Chemical-based             

• Conjugation             

• Photoreaction

Nucleic Acid Labeling Application Outlook (Revenue, USD Million, 2016 – 2027)    

• Oligonucleotide Labeling     

• In-situ Hybridization     

• Southern & Northern Blotting     

• Cellular Localization     

• Others

Nucleic Acid Labeling Sector Outlook (Revenue, USD Million, 2016 – 2027)    

• Diagnostics     

• Research     

• Therapeutics

Nucleic Acid Labeling Regional Outlook (Revenue, USD Million, 2016 – 2027)     

North America        

• The U.S.         

• Canada     

• Europe         

• Germany         

• The U.K.         

• France     

• Asia Pacific         

• China         

• India         

• Japan     

• Central and South America         

• Brazil     

• Middle East & Africa (MEA)         

• South Africa

List of Key Players of Nucleic Acid Labeling Market     

PerkinElmer, Inc.     

F. Hoffmann La-Roche AG     

Cytiva     

Thermo Fisher Scientific Inc.     

Promega Corporation     

New England Biolabs     

Enzo Biochem, Inc.

 

Fill The Pre-Order Enquiry Form For The Report @ https://www.grandviewresearch.com/inquiry/451121/ibb

 

About Grand View Research

Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/nucleic-acid-labeling-market

view more articles

About Article Author